Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial
Zhang, Li, Prof, Ma, Shenglin, MD, Song, Xiangqun, MSc, Han, Baohui, MD, Cheng, Ying, MSc, Huang, Cheng, MD, Yang, Shujun, MD, Liu, Xiaoqing, MD, Liu, Yunpeng, MD, Lu, Shun, MD, Wang, Jie, MD, Zhang, Shucai, MD, Zhou, Caicun, MD, Zhang, Xiangwei, MD, Hayashi, Nobuya, BA, Wang, Mengzhao, MD
Published in The lancet oncology (01.05.2012)
Published in The lancet oncology (01.05.2012)
Get full text
Journal Article
Phase 1 Study of the Selective c-MET Inhibitor, HS-10241, in Patients With Advanced Solid Tumors
Dong, Xiaorong, Li, Xingya, Chen, Jianhua, Ma, Shenglin, Mu, Deguang, Hu, Jie, Lu, Shun
Published in JTO clinical and research reports (01.02.2023)
Published in JTO clinical and research reports (01.02.2023)
Get full text
Journal Article